Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9871633rdf:typepubmed:Citationlld:pubmed
pubmed-article:9871633lifeskim:mentionsumls-concept:C1704689lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0226896lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0205531lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C1527415lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0008380lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0444626lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0072662lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0043309lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C1260969lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:9871633lifeskim:mentionsumls-concept:C0676239lld:lifeskim
pubmed-article:9871633pubmed:issue1lld:pubmed
pubmed-article:9871633pubmed:dateCreated1999-1-26lld:pubmed
pubmed-article:9871633pubmed:abstractTextThe synthesis, single crystal X-ray structural analysis, and biological activity of FR186054 (2c), a new, potent, orally efficacious inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT), containing a pyrazole ring are described. This compound displayed excellent in vitro efficacy, irrespective of dosing method, indicating superior characteristics compared to other ACAT inhibitors.lld:pubmed
pubmed-article:9871633pubmed:languageenglld:pubmed
pubmed-article:9871633pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871633pubmed:citationSubsetIMlld:pubmed
pubmed-article:9871633pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871633pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871633pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871633pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871633pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871633pubmed:statusMEDLINElld:pubmed
pubmed-article:9871633pubmed:monthJanlld:pubmed
pubmed-article:9871633pubmed:issn0960-894Xlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:SawadaMMlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:TanakaAAlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:TanakaHHlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:SakumaYYlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:KinoshitaTTlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:TerasawaTTlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:TakasugiHHlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:IshibeNNlld:pubmed
pubmed-article:9871633pubmed:authorpubmed-author:HagiharaHHlld:pubmed
pubmed-article:9871633pubmed:issnTypePrintlld:pubmed
pubmed-article:9871633pubmed:day6lld:pubmed
pubmed-article:9871633pubmed:volume8lld:pubmed
pubmed-article:9871633pubmed:ownerNLMlld:pubmed
pubmed-article:9871633pubmed:authorsCompleteYlld:pubmed
pubmed-article:9871633pubmed:pagination81-6lld:pubmed
pubmed-article:9871633pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:meshHeadingpubmed-meshheading:9871633-...lld:pubmed
pubmed-article:9871633pubmed:year1998lld:pubmed
pubmed-article:9871633pubmed:articleTitleSynthesis, X-ray crystal structure, and biological activity of FR186054, a novel, potent, orally active inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT) bearing a pyrazole ring.lld:pubmed
pubmed-article:9871633pubmed:affiliationMedicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan.lld:pubmed
pubmed-article:9871633pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:9871633lld:chembl